Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 21, 2022
- Revision received June 8, 2022
- Accepted June 9, 2022
- Published online September 7, 2022.
Copyright & Usage
Copyright © 2022, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).
Author Information
- DIRK RADES1⇑,
- JASPAR WITTELER1,
- PETER TRILLENBERG2,
- DENISE OLBRICH3,
- STEVEN E. SCHILD4,
- SØREN TVILSTED5 and
- TROELS W. KJAER6
- 1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany;
- 2Department of Neurology, University of Lübeck, Lübeck, Germany;
- 3The Centre for Clinical Trials Lübeck, University of Lübeck, Lübeck, Germany;
- 4Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U.S.A.;
- 5Research Projects and Clinical Optimization, Zealand University Hospital, Køge, Denmark;
- 6Neurological Department, Zealand University Hospital, Roskilde, Denmark
- Correspondence to: Prof. Dirk Rades, MD, Department of Radiation Oncology, University of Lübeck, Ratzeburger Allee 160, 23562 Lübeck, Germany. Tel: +49 45150045401, Fax: +49 45150045404, e-mail: dirk.rades{at}uksh.de